Altravax

is engaged in the discovery and development of vaccines for infectious diseases...
Read more
Altravax Interim-CEO: Michael Chambers

Interim-CEO

Michael Chambers

CEO Approval Rating

70/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$2M

Altravax Competitors

1Dynavax
2GlobeImmune
3Agenus
4Seqirus
5Trius Therapeutics
6OncoMed Pharmaceuticals
7Stemline
8Aduro Biotech
9Verastem Oncology
10Cempra

Trending Companies